- Advertisement -

U.S. FDA Issues Draft Guidance on Transfer of Premarket Notification

The U.S. Food and Drug Administration (FDA) has issued a draft Guidance on transferring a premarket notification (510(k)) clearance from one person to another.

The FDA estimates that there are more than 2000 instances of more than one party claiming to be the holder of a 510(k) clearance for a specific device under the agency’s annual registration and listing process. Published in the Federal Register in mid-March, the draft Guidance identifies potential documentation that a party could submit to the FDA to establish the transfer of a 510(k) clearance, thereby helping to reduce the number of conflicting claims.

Guidance documents are intended only to reflect the agency’s current thinking on a given subject and do not have the force of law. However, they can provide device developers and manufacturers with critical information to ensure an efficient device review process and a successful outcome.

Comments on the draft Guidance must be submitted by April 12th and should be emailed to oira_submissions@omb.eop.gov. All submissions should reference both Docket No. FDA-2014-D-1837, OMB control number 0910-New, and title “Transfer of a Premarket Notification.”

- Advertisement -

Read the complete text of the FDA’s Guidance as published in the Federal Register.

Sign up for the In Compliance Email Newsletter

Discover new products, review technical whitepapers, read the latest compliance news, and trending engineering news.

Exit mobile version
X